...
首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate
【24h】

Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate

机译:酒石酸唑吡坦多颗粒漂浮给药系统的设计与体外评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Zolpidem tartarate is a non-benzodiazepine, sedative-hypnotic, which finds its major use in various types of insomnia. The present work relates to development of multiparticulate floating drug delivery system based on gas generation technique to prolong the gastric residence time and to increase the overall bioavailability. Modified release dosage form of zolpidem tartarate adapted to release over a predetermined time period, according to biphasic profile of dissolution, where the first phase is immediate release phase for inducing the sleep and the second phase is modified release phase for maintaining the sleep up to 10h. The system consists of zolpidem tartarate layered pellets coated with effervescent layer and polymeric membrane. The floating ability and in vitro drug release of the system were dependent on amount of the effervescent agent (sodium bicarbonate) layered onto the drug layered pellets, and coating level of the polymeric membrane (Eudragit? NE 30D). The system could float completely within 5min and maintain the floating over a period of 10h. The multiparticulate floating delivery system of zolpidem tartarate with rapid floating and modified drug release was obtained.
机译:酒石酸唑吡坦是一种非苯二氮卓类镇静催眠药,主要用于各种失眠症。目前的工作涉及基于气体产生技术的多颗粒漂浮药物递送系统的开发,以延长胃的停留时间并增加整体生物利用度。酒石酸唑吡坦的缓释剂型适于根据溶解的双相曲线在预定时间段内释放,其中第一阶段是诱导睡眠的速释阶段,第二阶段是维持睡眠长达10h的改良释放阶段。该系统由涂有泡腾层和聚合物膜的酒石酸唑吡坦分层丸组成。该系统的漂浮能力和体外药物释放取决于层积在药物层状药丸上的泡腾剂(碳酸氢钠)的量以及聚合物膜的涂层水平(Eudragit?NE 30D)。系统可以在5分钟内完全漂浮,并在10小时内保持漂浮状态。获得了酒石酸唑吡坦的多颗粒漂浮递送系统,其具有快速漂浮和修饰的药物释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号